<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04231890</url>
  </required_header>
  <id_info>
    <org_study_id>18112803</org_study_id>
    <nct_id>NCT04231890</nct_id>
  </id_info>
  <brief_title>Early Identification and Prevention of Extubation Failure in Adults Using Integrated Pulmonary Index</brief_title>
  <acronym>IPI</acronym>
  <official_title>Early Identification and Prevention of Extubation Failure in Adults Using Integrated Pulmonary Index: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rush University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rush University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of this study is to compare reintubation rate when using standard medical&#xD;
      therapy (SMT) versus a monitoring tool, Integrated Pulmonary Index (IPI), to alert clinicians&#xD;
      of the patient's respiratory status and need for therapy after planned extubation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is designed as a randomized controlled trial to compare two methods to guide&#xD;
      application of clinical interventions after planned extubation: SMT versus IPI based clinical&#xD;
      management among adult patients admitted in the ICU and receiving mechanical ventilation for&#xD;
      ≥24 hours. Each mechanically ventilated subject within the inclusion criteria and with a&#xD;
      physician order for extubation will be randomized to either the SMT or IPI based clinical&#xD;
      management group. Once the extubation order is placed by the medical team, the patient will&#xD;
      be randomized to IPI monitoring group or standard medical management group. Patients&#xD;
      randomized to IPI group will be placed on IPI monitoring after extubation.Respiratory&#xD;
      Therapist (RT) will extubate and connects the patient to EtCO2 cannula (Medtronic,&#xD;
      Minneapolis, MN) and will turn on IPI monitoring on the Philips monitor. Any subject with&#xD;
      decrease in IPI by 1 within 1 hour of extubation or IPI ≤ 4 after 1 hour of extubation will&#xD;
      be assessed by RT and will receive standard medical therapy based on respiratory department&#xD;
      protocols. IPI monitoring will be continued for up to 72 hours after extubation. Patients&#xD;
      randomized to control group will receive standard medical therapy based on the respiratory&#xD;
      department protocols. All patients will be clinically monitored for 72 hours after extubation&#xD;
      to assess the extubation outcome. Patients that require reintubation will be reintubated&#xD;
      based on the medical team decision and will be discontinued from the study. Patients that do&#xD;
      not require reintubation after 72 hours will successfully complete the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 9, 2020</start_date>
  <completion_date type="Actual">April 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reintubation rate at 72hours</measure>
    <time_frame>72 hours</time_frame>
    <description>Reintubation rate defined as requiring re-intubation and returning to mechanical ventilation within 72 hours after the initial discontinuation from the ventilation due to respiratory failure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reintubation rate at 7 days</measure>
    <time_frame>7 days</time_frame>
    <description>Reintubation rate defined as requiring re-intubation and returning to mechanical ventilation within 7 days after the initial discontinuation from the ventilation due to respiratory failure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>upto 12 weeks</time_frame>
    <description>Total ICU day</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU mortality</measure>
    <time_frame>upto 12 weeks</time_frame>
    <description>Patient status at the time of ICU discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">174</enrollment>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Extubation</condition>
  <arm_group>
    <arm_group_label>IPI group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>IPI monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IPI monitoring</intervention_name>
    <description>Patients in this arm will have IPI monitoring</description>
    <arm_group_label>IPI group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects 18 years and older, endotracheally intubated and receiving assisted&#xD;
             mechanical ventilation for more than 24hours, and&#xD;
&#xD;
          -  Subjects under planned extubation based on the medical team approval&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subjects who are less than 18 years old,&#xD;
&#xD;
          -  are pregnant,&#xD;
&#xD;
          -  have tracheostomy tube as they do not qualify for extubation,&#xD;
&#xD;
          -  have do-not-resuscitate or do-not-intubate orders,&#xD;
&#xD;
          -  accidental or self-extubated patients,&#xD;
&#xD;
          -  reintubation after study enrollment,&#xD;
&#xD;
          -  are extubated terminally, or&#xD;
&#xD;
          -  receiving extracorporeal membrane oxygenation (ECMO)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Vines, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>January 13, 2020</study_first_submitted>
  <study_first_submitted_qc>January 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 18, 2020</study_first_posted>
  <last_update_submitted>April 6, 2021</last_update_submitted>
  <last_update_submitted_qc>April 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rush University Medical Center</investigator_affiliation>
    <investigator_full_name>Ramandeep Kaur</investigator_full_name>
    <investigator_title>Research Coordinator; MSc, RRT-ACCS, AE-C</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

